Isak W Tengesdal

Years Active: 2018-2021
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Raffaella Molteni, Riccardo Biavasco, Davide Stefanoni, Travis Nemkov, Mihai G Netea, Rob J W Arts, Ivan Merelli, Davide Mazza, Samuel Zambrano, Maddalena Panigada, Eleonora Cantoni, Isak W Tengesdal, Philippe Maksud, Francesco Piras, Daniela Cesana, Laura Cassina, Gianfranco Distefano, Alessia Loffreda, Daniela Gnani, Giacomo De Luca, Alessandro Tomelleri, Campochiaro Corrado, Leo A B Joosten, Charles A Dinarello, Anna Kajaste-Rudnitski, Julien Haroche, Simone Cardaci, Simone Cenci, Lorenzo Dagna, Claudio Doglioni, Marina Ferrarini, Elisabetta Ferrero, Alessandra Boletta, Angelo D'Alessandro, Eugenio Montini, Mihai G Netea, Giulio Cavalli
Oncogene-induced maladaptive activation of trained immunity in the pathogenesis and treatment of Erdheim-Chester disease. Blood 138 (17) (2021)
Isak W Tengesdal, David Kitzenberg, Suzhao Li, Melanie S Nyuydzefe, Wei Chen, Jonathan M Weiss, Jingya Zhang, Samuel D Waksal, Alexandra Zanin-Zhorov, Charles A Dinarello
The selective ROCK2 inhibitor KD025 reduces IL-17 secretion in human peripheral blood mononuclear cells independent of IL-1 and IL-6. European journal of immunology 48 (10) (2018)

Isak W Tengesdal.css-eqlu8i{font-size:small;padding-left:4px;}